Mice immunized with TcVac2 responded to T. cruzi infection with a rapid and potent expansion of type 1 antibodies, CD8+ T cells, and proinflammatory cytokines that effectively controlled the acute parasitemia and tissue parasite burden. This evidence concerns the gene CD8A and parasitic infectious disease.